Only going to update twitter on these positions on News, not on the daily swings. Will update this blog every other week on these positions. Not much has changed, but below is how it looks for July-August: SQNM - Still in 2k from 3.50, good till cancel stop at 2.75. This is in a slow drift downward, and could be lifeless all summer because not expecting down syndrome results till q4. Holding SQNM into it’s third party validated results unless stopped out before they come out. ARNA - in 5k from 4.57. Will double down at 4 if ARNA hits there this summer. Waiting for BLOSSOM results in September, and ARNA will likely give us a heads up before they happen. I don’t imagine ARNA going below 4 before blossom results after it’s successfull capital raise above 5. Volume is extremely light, nothing new here. XOMA - In 20k at .91. Did not add to position yet, but considering it. XOMA only works if the market is speculative, which since mid June, it has not been. However, I am holding on for the below reason. Right now mental stop .60, which is 10% below it’ price it was on expanded Cimzia royalties, and is about 50% it’ price of it’s secondaries. If XOMA does not work, it’s because the market is not speculative enough to make it happen. Waiting for the below event: 08-Jun-09 09:04 ET XOMA XOMA Limited: Positive data at ADA and more in July/Aug likely to boost XOMA shares - RBC (1.06 ) -Update RBC notes new Phase I data presented this weekend at the Ameican Diabetes Association meeting (ADA) confirmed and expanded on the previously demonstrated efficacy of XOMA 052 in patients with type II diabetes. They note the data showed 1) a convincing improvement in glucose control as measured by a reduction in HbA1c, 2) more robust efficacy than previous Phase I disclosures, 3) a dose response, 4) no new safety concerns, and 5) a benefit in important measures of disease progression and improvement. They anticipate more positive data in July and July/Aug, leading to initiation of robust Phase II trials and a potential large pharma deal in H2:09. LAVA - In 15k at 1.33 for a longer term trade than any of the above. Read the last ‘earnings’ transcript here: http://seekingalpha.com/article/139974-magma-design-automation-inc-f4q09-qtr-end-05-01-09-earnings-call-transcript?source=yahoo I like the cash flow positive aspect of the company, and the talis 1.1 router product looks to be a potential hit. I don’t like the big drop off in backlog. This is a 2010 story. Will update the twitter on news events, but will update this blog every two weeks regarding these positions going forward. Good luck - Welsh